|7.71||-0.17 / -2.16%|
Data as of 1:00pm ET
|7.71||-0.0009 / -0.01%|
The 4 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 20.50, with a high estimate of 40.00 and a low estimate of 16.00. The median estimate represents a +165.89% increase from the last price of 7.71.
The current consensus among 4 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.